Next Generation News and Research

RSS

UH pharmacy students receive awards for excellence in clinical skills, disease management

University of Houston pharmacy students wrapped up the spring semester with awards for excellence in professional service, clinical skills and disease management, earning kudos at the state level from the Texas Society of Health-System Pharmacists.

22 May 2015

CWRU's Frances Payne Bolton School of Nursing receives grant to study multiple chronic conditions

Case Western Reserve University's Frances Payne Bolton School of Nursing will begin training predoctoral and postdoctoral researchers to study people with multiple chronic illnesses in hopes of discovering better methods for managing such a complex combination of illnesses.

19 May 2015

DyAnsys' new non-narcotic treatment solution may provide relief to chronic pain sufferers

Chronic pain sufferers may find relief with a new, safe and effective non-narcotic treatment solution released by medical device maker DyAnsys, Inc. The company announced today that the four-piece system will be available in select doctors' offices and pain management centers.

19 May 2015

UMD expert working to accelerate development of improved implantable cardiac devices

A University of Maryland expert in the model-based testing of embedded software is working to accelerate the development of improved implantable medical devices used in the treatment of heart disease.

19 May 2015

Study quantifies different mutational profiles of tumour cell clusters in patients with bowel cancer

Bowel cancer is often driven by mutations in one of several different genes, and a patient can have a cancer with a different genetic make-up to another patient's cancer. Identifying the molecular alterations involved in each patient's cancer enables doctors to choose drugs that best target specific alterations.

19 May 2015

Studies support use of ThyraMIR and ThyGenX to improve detection of benign/malignant thyroid nodules

Data will be presented at both Digestive Disease Week (DDW) and the American Association of Clinical Endocrinologists (AACE) annual medical meetings.

18 May 2015

New affordable advanced NGS cancer test launched by EKF subsidiary

This new NGS panel molecular test is an important step towards readily accessible and affordable personalized medicine in cancer...

From EKF Diagnostics 15 May 2015

Researchers discover how and where chromosome fragile sites occur in human DNA

Using a novel method they developed to map chromosome breaks in a model organism, the budding yeast, Wenyi Feng, Ph.D., of Upstate Medical University and her colleagues have discovered new information as to how and where chromosome fragile sites can occur in human DNA. These sites are frequently observed in cancer cells and are responsible for causing genomic rearrangements.

15 May 2015

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

The American Pain Society today honored the recipients of its annual Clinical Centers of Excellence in Pain Management Awards recognizing the nation's outstanding pain care centers. Five multidisciplinary pain programs were recognized.

15 May 2015

New genomics laboratory in Liberia enables scientists to monitor genetic changes in Ebola virus

Army scientists working to support the Ebola virus outbreak response in West Africa have established the first genomic surveillance capability in Liberia, enabling them to monitor genetic changes in the virus within one week of sample collection. An article describing their work was recently published ahead of print in the online edition of Emerging Infectious Diseases.

15 May 2015

Mifepristone-eribulin combination clinically active in triple-negative breast cancer patients

Corcept Therapeutics Incorporated, a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today announced results of a multi-center Phase 1/2 dose-escalation study of mifepristone and chemotherapy drug eribulin (Halaven) that show it is well tolerated and clinically active in patients with triple-negative breast cancer.

15 May 2015

MO BIO announces launch of PowerMag DNA Clean-Up Kit

MO BIO Laboratories, Inc., the leader in soil, environmental, plant and microbial nucleic acid purification, announces the launch of the PowerMag DNA Clean-Up Kit, for automated, hands-free clean-up of DNA samples that require a secondary purification for removal of PCR inhibitors. This kit features MO BIO's novel ClearMag magnetic bead technology.

14 May 2015

Brain & Behavior Research Foundation to award grants to 40 scientists for research into mental illness

The Brain & Behavior Research Foundation today announced its 2015 Independent Investigator Grants which will award $3.9 million in funding to 40 mid-career scientists from 30 institutions in 16 countries.

14 May 2015

HHMI selects two Boston University medical students to conduct full-time biomedical research

Two medical students from Boston University have been selected by the Howard Hughes Medical Institute to conduct full-time biomedical research in its Medical Research Fellows Program. Joseph Park and Jacqueline Estevez are two of the selected 68 top medical and veterinary students from 37 different schools in the United States to receive this honor.

14 May 2015

TGen-led study associates 'X-linked' syndromes to genetic origins

A study led by the Translational Genomics Research Institute has for the first time matched dozens of infantile diseases and syndromes involving muscle weakness and stiff joints to their likely genetic origins.

14 May 2015

Researchers develop new tool to identify common genetic anomalies in cancer

Researchers from the University of Michigan Comprehensive Cancer Center and Thermo Fisher Scientific have developed and tested a new tool that searches for the most common genetic anomalies seen in cancer. The assay demonstrates the ability to make gene sequencing easier over a large volume of samples.

13 May 2015

Research findings could lead to new targeted treatments for aggressive subtype of lymphoma

An international team of researchers, including Lukas Kenner from the Clinical Department of Pathology at MedUni Vienna, has discovered a specific combination of mutations and new gene fusions, which are heavily implicated in tumour growth in patients with a particularly aggressive subtype of lymphoma (ALCL).

11 May 2015

CHOP's patient safety team recognized for work alarm fatigue in hospital units

A patient safety team at The Children's Hospital of Philadelphia who analyzed the problem of alarm fatigue in hospital units has been recognized for the best research paper of 2014 in a journal dedicated to biomedical technology.

8 May 2015

Cyclenium Pharma, Haplogen sign agreement to discover novel pharmaceutical candidates

Cyclenium Pharma Inc., an emerging pharmaceutical company specializing in the research and development of novel drug candidates based on its proprietary macrocyclic chemistry technology, and Haplogen GmbH, a biotechnology company developing anti-infective drugs, today announced the signing of a research agreement aimed at the discovery of novel pharmaceutical candidates in multiple disease areas.

7 May 2015

Quest Diagnostics launches genomic test service that aids in diagnosis for myeloid neoplasms

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced LeukoVantage, an evidence-based genomic test service that aids in the diagnosis, prognosis, monitoring and selection of treatment for myeloid neoplasms, a group of hematologic malignancies that includes acute myeloid leukemia (AML), the most common form of adult acute leukemia, as well as myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPNs).

From Quest Diagnostics 7 May 2015

Next Generation News and Research

UH pharmacy students receive awards for excellence in clinical skills, disease management

CWRU's Frances Payne Bolton School of Nursing receives grant to study multiple chronic conditions

DyAnsys' new non-narcotic treatment solution may provide relief to chronic pain sufferers

UMD expert working to accelerate development of improved implantable cardiac devices

Study quantifies different mutational profiles of tumour cell clusters in patients with bowel cancer

Studies support use of ThyraMIR and ThyGenX to improve detection of benign/malignant thyroid nodules

New affordable advanced NGS cancer test launched by EKF subsidiary

Researchers discover how and where chromosome fragile sites occur in human DNA

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

New genomics laboratory in Liberia enables scientists to monitor genetic changes in Ebola virus

Mifepristone-eribulin combination clinically active in triple-negative breast cancer patients

MO BIO announces launch of PowerMag DNA Clean-Up Kit

Brain & Behavior Research Foundation to award grants to 40 scientists for research into mental illness

HHMI selects two Boston University medical students to conduct full-time biomedical research

TGen-led study associates 'X-linked' syndromes to genetic origins

Researchers develop new tool to identify common genetic anomalies in cancer

Research findings could lead to new targeted treatments for aggressive subtype of lymphoma

CHOP's patient safety team recognized for work alarm fatigue in hospital units

Cyclenium Pharma, Haplogen sign agreement to discover novel pharmaceutical candidates

Quest Diagnostics launches genomic test service that aids in diagnosis for myeloid neoplasms

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News